Jeffery R Sampson

Title: Jeffery R Sampson: Innovator in Nucleic Acid Hybridization Techniques

Introduction

Jeffery R Sampson is an accomplished inventor based in Burlingame, California. With a focus on advancements in diagnostic techniques, he has contributed significantly to the field of nucleic acid hybridization.

Latest Patents

Jeffery holds a patent for "Arrays comprising background features that provide for a measure of a non-specific binding and methods for using the same." This innovative method enhances detection and analysis in nucleic acid hybridization assays by providing a reliable estimation of background signals primarily derived from nonspecific hybridization. His invention has potential applications in various fields including chemical, biological, medical, and diagnostic techniques, as well as drug discovery.

Career Highlights

Jeffery is affiliated with Agilent Technologies, Inc., where he applies his expertise in developing innovative solutions for nucleic acid detection. His work plays a vital role in improving the accuracy and reliability of diagnostic processes.

Collaborations

Throughout his career, Jeffery has collaborated with notable colleagues, including Glenda Choate Delenstarr and Steven M Lefkowitz. These collaborations have enhanced his research and fostered an environment of innovation within his team.

Conclusion

Jeffery R Sampson's contributions to nucleic acid hybridization techniques exemplify the spirit of innovation. His patent reflects a commitment to advancing diagnostic methodologies, ultimately benefiting medical and research communities. As he continues to work with Agilent Technologies, Inc., his impact on the field is expected to grow, marking him as a valuable inventor in the scientific landscape.